- Home
- asco conference coverage
Stay Ahead of the Curve with Our Comprehensive ASCO Coverage
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together approx 40K researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
Our team acknowledged thousands of scientific abstracts presented at every ASCO Annual Meeting based on the updates and findings from various cancer clinical trials, including revolutionizing new therapeutic research and changing the perspective of cancer patient care. We have also tracked all the social media platforms for all the possible hashtags around ASCO and helped the clients in gaining breakthroughs in the oncology domain.
Oncology Conference Coverage Services
Detailed analysis of conference coverage outcomes of various conferences, including ASCO, ESMO, ASH, and others.
Oncology Portfolio Management
Comprehensive services tailored to optimize strategic decision-making & maximize value across the oncology pipeline
Rare Diseases Analysis
R&D development evaluation to carry out the desired development of an oncological product for commercial purposes
Consulting Services
Credible consultancy services that aid in the acceleration of oncology product services, including CI asset/indication tracking, drug therapy uptake, & many more.
Reach Out Today!
Contact us for exclusive coverage of the ASCO conference.
Don't miss out!
Past ASCO Events
ASCO 2023: Insights and Analysis
AZ’s Tagrisso or Novartis’ Kisqali, find out who ruled in the ASCO 2023
ASCO 2022 Conference
Get a snapshot of all the ENHERTU breast cancer data presented at ASCO 2022
ASCO 2021 Annual Meeting
From targeted therapies to immunotherapies, uncover all lung cancer abstracts presented at ASCO 2021
ASCO 2020 Conference
Get a detailed analysis of how cell therapies performed at ASCO 2020
Case Study
Learn how a big pharma company leveraged conference coverage solutions to comprehensively covert AACR 2022, ASCO 2022, and ESMO 2022 by meticulous conference planning
View Case Study
Discover how a large pharma company utilized CI for the indication HER2 negative breast cancer
View Case Study
Find out how a global pharma company evaluated the market potential of asset gained through acquisition
View Case Study
Learn how a medium pharma company analyzed current pipeline activity of TCR products for cancer
View Case Study
Find out how a global pharma company monitored the performances of its wide variety of newly launched oncology products based on Lead and Lag KPIs
View Case StudyWhy ASCO Conference Coverage Solutions
- Providing data-driven insights generated through interpretation of Key Oral Abstracts presentations inclusive of all relevant Session Types such as Mini Oral, Industry Satellite Symposium, Proffered paper session, Educational Sessions, and EONS sessions
- Insights driven through interaction with Presentors/Oncologists/Researchers on industry-affiliated Poster sessions.
- Providing all pivotal trials, Late Breaking Abstracts (LBAs), efficacy data of first-in-class therapies targeting novel mutations, along with key company collaborations taking place on-site.
- Providing a pre-conference program to showcase the range of topics covered in each indication for
- Prioritizing abstracts highlighting the most pressing patient needs in terms of cancer screening (MRD testing and Early cancer detections), early-stage cancer treatment, and mutation/protein detection for making accurate therapy decisions for relapsed/refractory patients.
- Connecting with Keynote speakers to understand geographical variations and challenges in terms of cancer screening and treatment recommendations, thereby understanding the differences in clinical practices within a small community of physicians.
- In-depth examinations of the latest updates from clinical trials and advancements in treatment approaches, coupled with shifts in treatment strategies resulting from the latest data and changes in conventional practices.
Get in Touch
Get Expert Consultation Now!
Our long-standing experience and rich expertise in the oncology domain can be a perfect partner for your pressing business problems. Our in-depth knowledge of the oncology pipeline, granular understanding of market dynamics, and acute perception of marketing nuances can help you create a highly successful plan for future performance.
Get in touch with us to discuss a potential partnership and to know more about what we can offer you.